Peregrine Pharma (PPHM) Posts Q1 Loss of $0.14, Misses Views

September 9, 2010 4:10 PM EDT
Peregrine Pharmaceuticals (Nasdaq: PPHM) reports Q1 loss of $0.14, versus the analyst estimate of ($0.11). Revenue for the quarter was $3.21 million, which compares to the estimate of $5.83 million.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Add Your Comment